- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03671980
IBD Self-management Website and Home Faecal Calprotectin Monitoring
Feasibility and Acceptability of an Inflammatory Bowel Disease Self-management Website and Home Faecal Calprotectin Monitoring After Treatment De-escalation
Studieöversikt
Status
Intervention / Behandling
Detaljerad beskrivning
IBD can be challenging to manage as disease flares are often unpredictable and rarely coincide with scheduled outpatient appointments. Websites are a novel way of assisting patients to take more control over monitoring and managing symptoms and have been shown to improve outcomes in some chronic diseases. The My Medical Record (MyMR) webiste was developed to help patients learn about IBD, access test results, monitor symptoms, and manage their medications, with email support from the IBD team.
The use of home faecal calprotectin monitoring will also be explored. This marker of IBD activity is normally performed in hospital laboratories and becomes elevated before the onset of clinical symptoms of an IBD flare. New technologies enable patients to perform the test at home with the aid of a smartphone application.
A 6 month exploratory feasibility study will be conducted to assess if a combination of MyMR and a home faecal testing kit is a feasible and acceptable means for patients to monitor their illness. Their use will be targeted to patients who have recently stopped (or reduced) a treatment for IBD, as up to 50% of these patients may have a disease flare within a year.
Interventions
- Clinic appointments Study participants will not be required to attend any routine outpatient follow up appointments for the 6 month study period, after which they will be reviewed by a member of the IBD team.
- Questionnaires and interviews Partcipants will receive questionnaires and a sample will also undergo interviews to explore their views regarding the website and stool test.
- Website
Participants will be encouraged to use all functions of the website at least monthly:
- Secure email messaging service
- IBD educational material
- Stool, nutritional and flare journals
- Blood and test results
Faecal calprotectin monitoring - monthly testing (or sooner if symptoms of a flare-up) using QuantonCal home faecal calprotectin smartphone application. Participants will test and monitor their FC levels monthly. The results will be overseen by the IBD team who will make contact within a week in the event of abnormal results if the participant has not already done so.
- Blood tests All participants will have a routine blood test at 0 and 6 months. Those taking azathioprine, mercaptopurine and methotrexate should continue regular blood monitoring (minimum of 3 monthly FBC, U&E, LFT and CRP) as usual practice. Participants will be provided with blood test results and explanations of their significance via MyMR. The results will be overseen by the IBD team who will make contact within a week in the event of abnormal results if the patient has not already done so.
- Safety Patients can contact the IBD team the email messaging service at any time for advice and support.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Hampshire
-
Southampton, Hampshire, Storbritannien, SO16 6YD
- Univesity Hospital Southampton NHS Foundation Trust
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Adults aged ≥ 18 years currently under secondary care outpatient follow up for IBD
- Diagnosed with IBD at least one year prior to study enrolment (to ensure patients are familiar with their disease and treatments)
- Stopped or reduced the dose of one or more treatments for IBD (for any reason) within the last 8 weeks
- Able to understand English and provide written consent.
- Own, or have regular (at least weekly) access to a smartphone +/- personal computer with internet
Exclusion Criteria:
- Inability to read, understand informed consent
- Inability to use a smartphone
- Likely requirement of IBD surgery within the study period
- Ileostomy
- Pregnancy or planned pregnancy within next 6 months
- Terminal illness with limited (< 1year) life expectancy
- Current participation in another IBD research study
- Any reason, in the opinion of the investigators, which is likely to make the patient unsuitable for the study
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Övrig
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Web-intervention
30 participants using a self-management website and home faecal calprotectin smartphone monitoring instead of usual outpatient follow up as a means of managing their inflammatory bowel disease for 6 months after stopping an IBD medication.
|
Website comprising patient records, blood and other test results, useful information on IBD, and messaging service to communicate with IBD team, plus home smartphone faecal calprotectin monitoring.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Faecal calprotectin testing completion rates
Tidsram: 6 months
|
Number of patients completing monthly faecal calprotectin testing
|
6 months
|
MyMR website usage
Tidsram: 6 months
|
Number of patients logging in to MyMR website at least monthly
|
6 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Recruitment
Tidsram: 6 months
|
Number of patients recruited per month
|
6 months
|
IBD email contact
Tidsram: 6 months
|
Number of email messaging contacts per patient to IBD specialist nursing team
|
6 months
|
IBD flareline calls
Tidsram: 6 months
|
Number of IBD flareline telephone calls per patient to IBD specialist nursing team
|
6 months
|
IT support contact
Tidsram: 6 months
|
Number of IT support email contacts per patient
|
6 months
|
Questionnaire response rates
Tidsram: 6 months
|
Response rates to pre-and post-study questionnaires
|
6 months
|
Retention rate
Tidsram: 6 months
|
Study retention rate (target 80%).
Study retention will be defined as successful completion of at least 5 out of 7 home faecal calprotectin tests, with no periods without login to website of greater than 3 consecutive months.
|
6 months
|
Calprotectin levels
Tidsram: 6 months
|
Mean faecal calprotectin levels at 0, 4, 8, 12, 16, 20, and 24 weeks.
|
6 months
|
IBD-Control
Tidsram: 6 months
|
Mean IBD-Control scores at 0, 4, 8, 12, 16, 20, and 24 weeks
|
6 months
|
SIBDQ
Tidsram: 6 months
|
Mean quality of life (SIBDQ) scores at 0 and 26 weeks
|
6 months
|
IBD knowledge
Tidsram: 6 months
|
Mean IBD knowledge scores (CC-KNOW) at 0 and 26 weeks.
|
6 months
|
Samarbetspartners och utredare
Samarbetspartners
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- RHM MED1269
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Inflammatoriska tarmsjukdomar
-
Seattle Children's HospitalImmunexpressAvslutadSepsis | Systemic Inflammatory Response Syndrome (SIRS)Förenta staterna
-
University of ArkansasAvslutadPediatriska patienter med SIRS (Systemic Inflammatory Response Syndrome)Förenta staterna
-
Chinese PLA General HospitalAvslutadSepsis | SIRS (Systemic Inflammatory Response Syndrome)Kina
-
Chinese PLA General HospitalOkändSepsis | SIRS (Systemic Inflammatory Response Syndrome)Kina
-
Arkansas Children's Hospital Research InstituteEunice Kennedy Shriver National Institute of Child Health and Human Development...AvslutadSIRS (Systemic Inflammatory Response Syndrome)Förenta staterna
-
ImmunexpressJohns Hopkins University; Northwell Health; Rush University Medical Center; Intermountain Health Care, Inc... och andra samarbetspartnersAvslutadSepsis | Systemic Inflammatory Response Syndrome (SIRS)Förenta staterna
-
University of CologneAvslutadSystemic Inflammatory Response Syndrome (SIRS)Tyskland
-
Forest LaboratoriesAvslutadSystemic Inflammatory Response Syndrome (SIRS) | Augmented Renal Clearance (ARC)Förenta staterna, Australien
-
University of TennesseeOkändSepsis | Septisk chock | Svår sepsis | Systemic Inflammatory Response Syndrome (SIRS)Förenta staterna
-
University Hospital, Strasbourg, FranceAvslutadChock | Systemic Inflammatory Response Syndrome (SIRS) | HypoalbuminemiFrankrike